| Product Code: ETC8287841 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Rare Biomarkers Specimen Collection and Stabilization Market - Industry Life Cycle |
3.4 Mexico Rare Biomarkers Specimen Collection and Stabilization Market - Porter's Five Forces |
3.5 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume Share, By Specimen, 2021 & 2031F |
3.8 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume Share, By Nucleic Acid and other Biomolecules, 2021 & 2031F |
3.9 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.10 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume Share, By End use, 2021 & 2031F |
4 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine and precision diagnostics driving the need for rare biomarkers specimen collection and stabilization. |
4.2.2 Growing research and development activities in the field of rare diseases and genetic disorders. |
4.2.3 Technological advancements improving the efficiency and effectiveness of specimen collection and stabilization processes. |
4.3 Market Restraints |
4.3.1 Regulatory challenges and stringent compliance requirements related to the collection and handling of rare biomarkers specimens. |
4.3.2 Limited awareness and understanding among healthcare professionals about the importance of rare biomarkers specimen collection and stabilization. |
4.3.3 High cost associated with specialized equipment and procedures for collecting and stabilizing rare biomarkers specimens. |
5 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Trends |
6 Mexico Rare Biomarkers Specimen Collection and Stabilization Market, By Types |
6.1 Mexico Rare Biomarkers Specimen Collection and Stabilization Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Circulating Cell Free DNA (ccfDNA), 2021- 2031F |
6.1.4 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Circulating Tumor Cells (CTCs), 2021- 2031F |
6.1.5 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Exosomes/Extracellular Vesicles, 2021- 2031F |
6.2 Mexico Rare Biomarkers Specimen Collection and Stabilization Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Isolation Kits and Reagents, 2021- 2031F |
6.2.3 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Blood Collection Tubes, 2021- 2031F |
6.2.4 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Systems, 2021- 2031F |
6.3 Mexico Rare Biomarkers Specimen Collection and Stabilization Market, By Specimen |
6.3.1 Overview and Analysis |
6.3.2 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Serum/Plasma, 2021- 2031F |
6.3.3 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Mexico Rare Biomarkers Specimen Collection and Stabilization Market, By Nucleic Acid and other Biomolecules |
6.4.1 Overview and Analysis |
6.4.2 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By RNA, 2021- 2031F |
6.4.3 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By DNA, 2021- 2031F |
6.4.4 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Mexico Rare Biomarkers Specimen Collection and Stabilization Market, By Application |
6.5.1 Overview and Analysis |
6.5.2 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By NIPT, 2021- 2031F |
6.5.3 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Oncology, 2021- 2031F |
6.5.4 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Transcriptomics, 2021- 2031F |
6.5.5 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Pharmacogenomics, 2021- 2031F |
6.5.6 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Transplant Rejection, 2021- 2031F |
6.5.7 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Population Screening, 2021- 2031F |
6.5.8 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Mexico Rare Biomarkers Specimen Collection and Stabilization Market, By End use |
6.6.1 Overview and Analysis |
6.6.2 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Perinatal Clinics, 2021- 2031F |
6.6.4 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Public Health Labs, 2021- 2031F |
6.6.5 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Private or Commercial Labs, 2021- 2031F |
6.6.6 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Physician Labs, 2021- 2031F |
6.6.7 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Research Institutes, 2021- 2031F |
7 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Import-Export Trade Statistics |
7.1 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Export to Major Countries |
7.2 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Imports from Major Countries |
8 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Key Performance Indicators |
8.1 Rate of adoption of advanced specimen collection and stabilization technologies in the market. |
8.2 Number of research studies and clinical trials utilizing rare biomarkers specimens in Mexico. |
8.3 Level of investment in infrastructure and training for healthcare professionals in the field of rare biomarkers specimen collection and stabilization. |
9 Mexico Rare Biomarkers Specimen Collection and Stabilization Market - Opportunity Assessment |
9.1 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Opportunity Assessment, By Specimen, 2021 & 2031F |
9.4 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Opportunity Assessment, By Nucleic Acid and other Biomolecules, 2021 & 2031F |
9.5 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Opportunity Assessment, By Application, 2021 & 2031F |
9.6 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Opportunity Assessment, By End use, 2021 & 2031F |
10 Mexico Rare Biomarkers Specimen Collection and Stabilization Market - Competitive Landscape |
10.1 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Revenue Share, By Companies, 2024 |
10.2 Mexico Rare Biomarkers Specimen Collection and Stabilization Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here